Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron

Drug
Mental health and psychosocial factors
Online since 16 April 2024, updated 157 days ago

About this trial

We propose to test the hypothesis that cognition will improve with substitution of mirabegron for the anticholinergic agent (AC) in elderly persons with spinal cord injury (SCI) who require neurogenic...

Included participants

Gender
All
Age
60 - 99 years
Injury level
C1 - S5
  • Severity (AIS)?
  • AIS-A
    AIS-B
    AIS-C
    AIS-D
    Time since injury
    ≥ 1 month
  • Injury type
  • Traumatic

    Non-traumatic

    Healthy volunteers
    No
    C1-S5

    What’s involved

    Type

    Drug

    Details

    There are no details yet

    Potential benefits

    Main benefits

    Mental health and psychosocial factors

    Additional benefits

    Bladder health/function

    Bowel health

    General health

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Ended
    • Trial start date
    • 5 Dec 2018
    • Organisation
    • The University of Texas Health Science Center at San Antonio
    • Trial recruitment status
    • Ended
    • Trial start date
    • 5 Dec 2018
    • Organisation
    • The University of Texas Health Science Center at San Antonio

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more